期刊文献+

胃癌组织中COX-2、VEGF和MMP-9的表达及临床意义 被引量:10

Expression and significance of COX-2, VEGF and MMP-9 in human gastric carcinoma
下载PDF
导出
摘要 目的探讨COX-2、VEGF和MMP-9在人胃癌组织中的表达及临床意义。方法应用免疫组化SABC法检测45例人胃癌组织中COX-2、VEGF和MMP-9的表达,并以30例正常胃黏膜组织作为对照。对COX-2、VEGF和MMP-9的表达采用平均光密度测定,并对临床相关资料进行统计学分析。结果胃癌组织中COX-2、VEGF和MMP-9的平均光密度值(OD)为(19.85±7.34)、(134.67±13.11)和(18.81±7.56)显著高于正常胃黏膜组织的表达[(12.49±4.87)、(83.89±8.74)和(11.46±4.82),P<0.01],癌组织中COX-2、VEGF和MMP-9的表达与性别、年龄、部位、组织类型、分化程度无相关性,而与肿瘤直径、TNM分期、淋巴转移、远处转移相关(P<0.05),同时经相关性分析发现在胃癌组织中,COX-2与VEGF和MMP-9表达有显著相关性(γ=0.473,P=0.005,γ=0.437,P=0.001),而VEGF与MMP-9之间无相关性(γ=0.142,P=0.467>0.05)结论COX-2可能诱导VEGF和MMP-9的表达而促进肿瘤血管的生成和侵袭转移。 Objective To study the expression of cyclooxygenase-2(COX-2), endothelial growth factor(VEGF) Matrix Metallo-Proteinase-9(MMP-9) in gastric carcinoma and it′s possible clinical significance.MethodsThe expression of COX-2, VEGF and MMP-9 were studied by immunohistochemistry SABC method in 45 gastric carcinoma specimen and 30 normal gastric tissues as control.The average light density was assayed by the expression of COX-2, VEGF and MMP-9, and the statistic software was used to analyze the clinical correlated...
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第21期3202-3206,共5页 China Journal of Modern Medicine
关键词 胃癌 COX-2 VEGF MMP-9 gastric carcinoma cyclooxygenase-2 vascular endothelial growth factor matrix metallo proteinase-9
  • 相关文献

参考文献3

二级参考文献26

  • 1Du-Hu Liu Xue-Yong Zhang Dai-Ming Fan Yu-Xin Huang Jin-Shan Zhang Wei-Quan Huang Yuan-Qiang Zhang Qing-Sheng Huang Wen-Yu Ma Yu-Bo Chai Ming Jin Institute of Digestive Disease,Xijing Hospital,~2 Department of Gastroenterology,Tangdu Hospital,~3Department of Histology and Embryology,~4 Department of Microbiology,~5 Department of Biochemistry,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma[J].World Journal of Gastroenterology,2001,7(4):500-505. 被引量:37
  • 2Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr,Blot WJ. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7:97-102.
  • 3Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonsteroidal antiinflammatory drugs. Epidemiology 2001; 12:88-93.
  • 4Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M, Kimura A, Komori M, Irie T, Miyoshi E, Sasaki Y, Hayashi N, Kawano S, Hori M. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 2002; 62:1567-1572.
  • 5Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T,Haglund C, Joensuu H, Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002; 62:632-635.
  • 6Joo YE, Oh WT, Rew JS, Park CS, Choi SK, Kim SJ.Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis.Digestion 2002; 66:222-229.
  • 7Morgan G. Beneficial effects of NSAIDs in the gastrointestinal tract. Eur J Gastroenterol Hepatol 1999; 11:393-400.
  • 8Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76:1116-1119.
  • 9Taketo-MM. Cyclooxygenase-2 inhibitors in tumorigenesis(Part Ⅱ). J Natl Cancer Inst 1998; 90:1609-1620.
  • 10Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S,Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55:3785-3789.

共引文献71

同被引文献135

引证文献10

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部